Who is sponsoring NCT04946058?

NCT04946058 is sponsored by Tanta University.

What drugs are being tested in NCT04946058?

Interventions in NCT04946058: hyebrid Mathieu Urethroplasty.

What condition does NCT04946058 study?

NCT04946058 studies Distal Penile Hypospadias (Disorder).

Is NCT04946058 still recruiting?

NCT04946058 is currently completed. Last updated 30 June 2021.

Last reviewed 2021-06-30 · How we verify

NCT04946058

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Hybrid Mathieu Urethroplasty

Completed NA Last updated 30 June 2021

What this trial tests

NA trial testing hyebrid Mathieu Urethroplasty in Distal Penile Hypospadias (Disorder) in 43 participants. Completed in 15 January 2021.

Timeline

31 March 2012

Primary endpoint
31 December 2020

15 January 2021

Quick facts

Lead sponsor	Tanta University
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	treatment
Enrollment	43
Start date	31 March 2012
Primary completion	31 December 2020
Estimated completion	15 January 2021

Drugs / interventions tested

hyebrid Mathieu Urethroplasty

Conditions studied

Distal Penile Hypospadias (Disorder) — all drugs for Distal Penile Hypospadias (Disorder) →

Sponsor

Tanta University

Who can join

Adults 6 Months to 4, male only, with Distal Penile Hypospadias (Disorder). Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

the aim is to study the results of simple modification of classic Mathieu urethroplasty to increase the scope of cases candidates for that procedure.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Tanta University trials

Trials by the same sponsor.

NCT07398651 — Apremilast and Adalimumab in Psoriatic Arthritis Patients · NA · not yet recruiting
NCT06966856 — This Randomized, Clinical Trial Evaluates the Efficacy of Oral Versus Sublingual Vitamin B12 Supplementation in Correcti · Phase 3 · not yet recruiting
NCT07334197 — Effect of Melatonin on Left Ventricular Reverse Remodeling and Inflammation in Peripartum Cardiomyopathy · NA · not yet recruiting
NCT07498998 — Glucocorticoid, Ozone and 5% Dextrose Local Injection for Pain Relief in Carpal Tunnel Syndrome · NA · not yet recruiting
NCT07114250 — Comparative Study Between Spinal Anesthesia Versus General Anesthesia in Supine Percutaneous Nephrolithotomy Operation · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04946058 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Tanta University
Last refreshed: 30 June 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04946058.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing